Global Myopia And Presbyopia Treatment Market 2023-2027
The myopia and presbyopia treatment market is forecasted to grow by USD 7946.29 mn during 2022-2027, accelerating at a CAGR of 8.09% during the forecast period. The report on the myopia and presbyopia treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of myopia and presbyopia, rising awareness regarding vision care, and growing demand for vision correction among the aging population.
Technavio's myopia and presbyopia treatment market is segmented as below:
By Type
- Myopia treatment
- Presbyopia treatment
By Product
- Lenses and glass
- Surgery
- Drug
By Geographical Landscape
- Asia
- North America
- Europe
- Rest of World (ROW)
This study identifies the recent developments in myopia and presbyopia treatment as one of the prime reasons driving the myopia and presbyopia treatment market growth during the next few years. Also, increasing medical tourism for low-cost ophthalmology surgeries and emergence of multifocal intraocular lenses will lead to sizable demand in the market.
The report on the myopia and presbyopia treatment market covers the following areas:
- Myopia and presbyopia treatment market sizing
- Myopia and presbyopia treatment market forecast
- Myopia and presbyopia treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading myopia and presbyopia treatment market vendors that include AbbVie Inc., Alcon Inc., Arctic Vision, Bausch Health Companies Inc., BVI Holdings Ltd., Carl Zeiss AG, ENTOD INTERNATIONAL, EssilorLuxottica, F. Hoffmann La Roche Ltd., Johnson and Johnson, Metall Zug AG, NIDEK Co. Ltd., Ophtec BV, Orasis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanjeevan School For Perfect Eyesight, Sydnexis Inc., The Cooper Companies Inc., Topcon Corp., Vision Care Group, Visus Therapeutics Inc., Ziemer Ophthalmic Systems AG, and Evotec SE. Also, the myopia and presbyopia treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.